{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:32Z","timestamp":1786996052011,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.prostaglandins.2020.106524","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T11:27:47Z","timestamp":1610191667000},"page":"106524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Trisomy 21 impairs PGE2 production in dermal fibroblasts"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-7459","authenticated-orcid":false,"given":"John O.","family":"Marentette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra M.","family":"Prutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6991-6098","authenticated-orcid":false,"given":"Erin Q.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek K.","family":"Rauniyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Galligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8425-6366","authenticated-orcid":false,"given":"James R.","family":"Roede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106524_bib0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejim.2015.05.003","article-title":"Clinical profile and main comorbidities of Spanish adults with Down syndrome","volume":"26","author":"Real de Asua","year":"2015","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106524_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","article-title":"The four ages of Down syndrome","volume":"17","author":"Bittles","year":"2007","journal-title":"Eur. J. Public Health"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106524_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/08880019209018329","article-title":"Leukemia in Down syndrome: a review","volume":"9","author":"Zipursky","year":"1992","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106524_bib0020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","article-title":"Down syndrome and Alzheimer\u2019s disease: common pathways, common goals","volume":"11","author":"Hartley","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106524_bib0025","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with down syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106524_bib0030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.5435\/00124635-200610000-00003","article-title":"Down syndrome in children: the role of the orthopaedic surgeon","volume":"14","author":"Caird","year":"2006","journal-title":"J. Am. Acad. Orthop. Surg."},{"issue":"10","key":"10.1016\/j.prostaglandins.2020.106524_bib0035","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00007632-199605150-00016","article-title":"Complications and long-term outcome of upper cervical spine arthrodesis in patients with Down syndrome","volume":"21","author":"Doyle","year":"1996","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106524_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOP.0b013e3282f35f19","article-title":"Down syndrome: orthopedic issues","volume":"20","author":"Mik","year":"2008","journal-title":"Curr. Opin. Pediatr."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106524_bib0045","doi-asserted-by":"crossref","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prostaglandins.2020.106524_bib0050","first-page":"5","article-title":"Trisomy 21 consistently activates the interferon response","author":"Sullivan","year":"2016","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.prostaglandins.2020.106524_bib0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","article-title":"Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology","volume":"14","author":"Harizi","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106524_bib0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0753-3322(02)00193-2","article-title":"Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies","volume":"56","author":"Tapiero","year":"2002","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106524_bib0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106524_bib0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106524_bib0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12958-018-0359-5","article-title":"Prostaglandin E2 involvement in mammalian female fertility: ovulation, fertilization, embryo development and early implantation","volume":"16","author":"Niringiyumukiza","year":"2018","journal-title":"Reprod. Biol. Endocrinol.: RB&E"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106524_bib0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/archdischild-2017-313654","article-title":"Use of prostaglandins in duct-dependent congenital heart conditions","volume":"103","author":"Singh","year":"2018","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106524_bib0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/00016359709115400","article-title":"Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome","volume":"55","author":"Barr-Agholme","year":"1997","journal-title":"Acta Odontol. Scand."},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106524_bib0090","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/j.1460-2075.1991.tb07745.x","article-title":"Gene dosage of CuZnSOD and Down\u2019s syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice","volume":"10","author":"Minc-Golomb","year":"1991","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106524_bib0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5114\/fn.2017.68582","article-title":"Early increased density of cyclooxygenase-2 (COX-2) immunoreactive neurons in Down syndrome","volume":"55","author":"Mulet","year":"2017","journal-title":"Folia Neuropathol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106524_bib0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00001756-199703240-00020","article-title":"Induction of cyclo-oxygenase 2 in brains of patients with Down\u2019s syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons","volume":"8","author":"Oka","year":"1997","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106524_bib0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0047-6374(01)00413-4","article-title":"Enhancement of lipopolysaccharide-stimulated cyclooxygenase-2 mRNA expression and prostaglandin E2 production in gingival fibroblasts from individuals with Down syndrome","volume":"123","author":"Otsuka","year":"2002","journal-title":"Mech. Ageing Dev."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106524_bib0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/00016350310002270","article-title":"Enhanced levels of prostaglandin E2, leukotriene B4, and matrix metalloproteinase-9 in gingival crevicular fluid from patients with Down syndrome","volume":"61","author":"Tsilingaridis","year":"2003","journal-title":"Acta Odontol. Scand."},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106524_bib0115","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/jid.2015.157","article-title":"Age-associated increase in skin fibroblast-derived prostaglandin E2 contributes to reduced collagen levels in elderly human skin","volume":"135","author":"Li","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106524_bib0120","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/carcin\/bgh176","article-title":"Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate","volume":"25","author":"Badawi","year":"2004","journal-title":"Carcinogenesis"},{"issue":"9B","key":"10.1016\/j.prostaglandins.2020.106524_bib0125","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1111\/j.1582-4934.2008.00430.x","article-title":"Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?","volume":"13","author":"Zidar","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106524_bib0130","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar8320","article-title":"PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo","volume":"4","author":"Loynes","year":"2018","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106524_bib0135","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2009.01.015","article-title":"Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration","volume":"136","author":"Goessling","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106524_bib0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.146.1.108","article-title":"Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines","volume":"146","author":"Betz","year":"1991","journal-title":"J. Immunol."},{"issue":"48","key":"10.1016\/j.prostaglandins.2020.106524_bib0145","doi-asserted-by":"crossref","first-page":"84489","DOI":"10.18632\/oncotarget.21060","article-title":"Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.prostaglandins.2020.106524_bib0150","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.archoralbio.2009.07.009","article-title":"Influences of interferon-gamma on cell proliferation and interleukin-6 production in Down syndrome derived fibroblasts","volume":"54","author":"Iwamoto","year":"2009","journal-title":"Arch. Oral Biol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106524_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002003","article-title":"Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens","volume":"7","author":"Allen","year":"2011","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106524_bib0160","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biochi.2010.02.007","article-title":"Prostaglandin E synthases: understanding their pathophysiological roles through mouse genetic models","volume":"92","author":"Hara","year":"2010","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106524_bib0165","doi-asserted-by":"crossref","first-page":"G1139","DOI":"10.1152\/ajpgi.00013.2010","article-title":"Role of microsomal prostaglandin E synthase-1 in the facilitation of angiogenesis and the healing of gastric ulcers","volume":"299","author":"Ae","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106524_bib0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-8","article-title":"Population-based study of congenital heart defects in Down syndrome","volume":"80","author":"Freeman","year":"1998","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106524_bib0175","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.CIR.53.4.728","article-title":"E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations","volume":"53","author":"Olley","year":"1976","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106524_bib0180","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/ALN.0b013e3182039f22","article-title":"Celecoxib impairs heart development via inhibiting cyclooxygenase-2 activity in zebrafish embryos","volume":"114","author":"Xu","year":"2011","journal-title":"Anesthesiology"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882320301179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882320301179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:02:06Z","timestamp":1761098526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882320301179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"alternative-id":["S1098882320301179"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106524","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trisomy 21 impairs PGE2 production in dermal fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106524"}}